RNA Society Meeting 2024

We attended the 2024 RNA Society Meeting in Edinburgh and had a great time talking about RNA biology and meeting people. Austin Herbert, Allie Randazza and Debarati Majumdar presented posters on their graduate research projects. Congratulations to Debarati for receiving an RNA Society Travel Award!

Lackey lab in at the closing dinner in the National Museum of Scotland.

Posters


Exploring alternative polyadenylation isoforms of DNMT3A

Debarati Majumdar, Austin Herbert, Lela Lackey


The DNMT3A (DNA methyl transferase) gene is known for its pivotal role in de novo DNA methylation and gene regulation. DNMT3A’s role in DNA methylation is well‐documented. However, DNMT3A produces various mRNA isoforms through alternative polyadenylation (APA) and alternative splicing. Each of these mRNA isoforms may be regulated differently in ways that could significantly impact the origins and progression of various DNMT3A‐associated conditions, such as acute myeloid leukemia (AML) and neurodevelopmental disorders. Our hypothesis is that specific mRNA isoforms of DNMT3A, resulting from alternative polyadenylation (APA) events, may display variable stability, unique subcellular localizations, and differential impacts on downstream gene expression, ultimately influencing the pathogenesis of disorders. As a preliminary dataset, we used GTEx, 1000 genomes and UCSC Genome browser to identify mRNA isoforms and check their levels in various tissues. Once we confirmed DNMT3A mRNA isoform variants, we constructed plasmids containing the 3’UTR of the DNMT3A gene linked to the nano luciferase reporter gene to quantitatively assess the 3’UTR’s effect on gene expression by monitoring nanoluciferase activity. Subsequently we will employ various molecular biology assays to investigate RNA stability including (Actinomycin D inhibition followed by qPCR) RNA localization (Fluorescence In Situ Hybridization; Cellular fractionation followed by qPCR) and translational efficiency (Polysome profiling) of these isoforms. Understanding the distinct roles of DNMT3A mRNA isoforms will not only advance our knowledge of the regulatory mechanisms underlying epigenetic control, but also lay the groundwork for isoform‐specific therapeutic interventions in DNMT3A‐associated diseases.

High‐throughput workflow to study the impact of mutations on RNA structure in the adenine riboswitch
Alexandra Randazza, FNU Jiamutai, Vijay Shankar, Lela Lackey


Directly linking individual RNA structures with function is difficult. We aim to create a workflow to determine the impact of specific RNA structures on RNA function. To do so, we incorporate mutations at specific positions in an RNA construct to alter individual structural elements and analyze the impact of altering those structures on function. We are developing a high‐throughput method to analyze hundreds to thousands of variants at once. For our initial tests, we are using the adenine riboswitch. The bacterial adenine riboswitch alters its structure upon binding adenine to facilitate the initiation of translation of an adenine deaminase protein. Purely computational structure analysis of mutant adenine riboswitch was unable to detect restoration of structure with rescue mutations. Our initial tests included six sequence variants that are expected to either destroy or maintain the aptamer’s structure. The ability of these variants to respond to adenine was first analyzed individually. In the future, we will pool them together. We have created a computational pipeline to separate each variant in the pool and generate structural data to measure the impact of the sequence variation on structure. We plan to expand this method to larger pools of mutants. To link mutations and structural changes to function, we will quantify the appropriate response of the adenine riboswitch to adenine. This will allow us to highlight structures that are essential in the adenine riboswitch and use this method to understand the role of RNA structure in other systems.

Precursor RNA structural patterns at SF3B1 mutation sensitive cryptic 3’ splice sites
Austin Herbert, Abigail Hatfield, Alexandra Randazza, Valeria Miyamoto, Katie Palmer, Lela Lackey


SF3B1, a core component of the spliceosome involved in branch point recognition and 3’ splice site selection is frequently mutated in human hematopoietic malignancies. Mice and zebra fish with conditional SF3B1 knock‐in mutations develop macrocytic anemia. A hallmark of SF3B1 mutation is an increased use of upstream cryptic 3’ splice sites (C3SS) in a broad number of genes, a finding that is recapitulated across multiple isogenic and patient cell types. Current studies suggest the common SF3B1 K700E mutation results in gain of function, allowing mutant SF3B1 spliceosomes to recognize cryptic 3’ splice sites normally inaccessible to the wild‐type protein. We asked whether precursor RNAs with SF3B1 K700E sensitive splice sites are structurally different from control cryptic 3’ splice sites. Utilizing publicly available bulk RNA sequencing data, we define a core set of 73 cryptic 3’ splice sites shared between isogenic SF3B1 K700E and myelodysplastic syndrome patient cell lines. Through a combination of experimental and in‐silico methods, we assess precursor RNA secondary structure in this subset of 3’ splice sites sensitive to cryptic mis‐splicing in SF3B1 mutant backgrounds. Occurring at a mean distance of 28 base pairs upstream, SF3B1 sensitive C3SS are significantly closer to their paired canonical splice sites than what is observed among control C3SS (mean 78 bp). Both SF3B1 sensitive and control C3SS contain a distinct polypyrimidine tract and a strong consensus AG splice site motif. Experimentally based structure models of intron‐exon junctions around SF3B1 sensitive C3SS reveals that cryptic sites structurally mimic their canonical counterparts. Despite structural mimicry at the immediate splice sites, cryptic 3’ splice sites lack downstream structural signatures observed in the exons of their paired canonical splice sites. We anticipate that SF3B1 mutation sensitive C3SS contain distinct structural patterns compared to control C3SS. These observations will yield insights on the modulation of cryptic 3’ splice site choice by precursor RNA secondary structures susceptible to mis‐splicing in SF3B1 mutants. Finally, we will use these findings to investigate a generalized mechanistic role of precursor RNA structures in contributing to regulation of cryptic 3’ splicing.

RNA Society of South Carolina opens its (virtual) doors!

The RNA Society of South Carolina is a group of researchers interested in coming together to discuss progress in the field of RNA Biology. We decided to found the Society based on increasing interest in RNA regulation and function within the Center for Human Genetics and the Department of Genetics and Biochemistry. In the last decade many developments in RNA Biology have highlighted the importance of studying these molecules. Some of these developments include awareness of the key nature of non-coding regions within protein coding messenger RNAs and the identification of long non-coding RNAs, small regulatory RNAs, circular RNAs and many other RNA species. All human diseases are influenced by RNA and, as a Society, we are interested in disorders that arise from malfunctions in RNA Biology.

The RNA Society of South Carolina aims to stay current on new RNA research, collaborate together as a diverse, multi-disciplinary group and creatively pursue research in RNA Biology. We want the junior scientists in our laboratories to excel and our RNA Society of South Carolina meetings are designed to help trainees learn exciting new research and practice presenting their own research. If you are interested in being a part of the RNA Society of South Carolina, hosted by Clemson University, please contact the RNA S&R group and we will invite you to our meetings.

Our first official meeting is November 2, 2020 at 2pm. We are planning an virtual introductory meeting where RNA researchers have the opportunity to share their work and connect with other local RNA scientists. We are currently funded by the International RNA Society and Lexogen as an RNA Salon. Thank you for your support!

RNA Society
Lexogen

Alpha1 Foundation Investigators’ 2020 Meeting

The Alpha1 Investigators’ Meeting is on November 6th from 12-7pm. Dr. Lackey is presenting the results of her work on SERPINA1 post-transcriptional regulation.

Project title: Developing an accurate model of human α-1-antitrypsin protein expression through RNA structure and function

Investigator(s): L. Lackey, A. Coria, I. Jimenez-Ruiz, P. Grayeski, Z. Xu, J. Platig. P. Castaldi, A. Laederach

Objectives: Alpha1 anti-trypsin (A1AT) protein is produced from the SERPINA1 mRNA. Normally, A1AT inhibits the immune protease neutrophil elastase, but if A1AT does not function properly, over-active neutrophil elastase damages the lungs. This lung damage leads to a predisposition toward chronic obstructive pulmonary disease (COPD), particularly in the smoking population. Variants within SERPINA1 can cause low levels of A1AT or misfolded A1AT, which are associated with lung and liver disease. Little is known about variants within non-coding regions of SERPINA1 that impact A1AT expression. Regulatory elements within the 5’ Untranslated Region (UTR) of SERPINA1 mRNA impact A1AT expression, suggesting that non-coding variants are important for A1AT-associated disease predisposition. SERPINA1 also has around 1700 nucleotides of 3’UTR sequence, and the role of this region is not well characterized in terms of its effect on A1AT expression. Objectives are to identify non-coding variants that influence A1AT expression, test whether 3’UTR elements regulate A1AT expression and determine their mechanism of action.

Results: We identify two novel 3’UTR isoforms generated by alternative polyadenylation (APA) in the SERPINA1 mRNA. The short isoform, created by cleavage at a proximal site, is common and highly expressed in all tissues with SERPINA1 mRNA expression. The longer 3’UTR isoform is primarily expressed in the liver and represses protein expression in a reporter system by over two orders of magnitude. Patients with COPD have increased amounts of the long SERPINA1 3’UTR isoform compared to patients without COPD in lung primary tissue.

Conclusion: Regulatory elements within the non-coding UTRs of SERPINA1 influence A1AT expression. COPD patients have disproportionately high amounts of long 3’UTR SERPINA1 isoforms, which are likely not able to effectively translate the A1AT protein, possibly contributing to their disease. Additional studies are necessary to understand the pathway that leads to increased use of the distal APA site in individuals with COPD. Variants that impact regulatory elements alter A1AT expression and influence A1AT-associated disease, such as the published 5’UTR variant rs568223361, which is associated with decreased A1AT levels and lung disease.